NCT04204434View on ClinicalTrials.gov

Biomarkers For Immune Checkpoint Inhibitors

CompletedOBSERVATIONAL

Enrollment

119

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

April 26, 2024

Conditions

Advanced CancerNeoplasms

Trial Locations (2)

02903

Rhode Island Hospital, Providence

02906

The Miriam Hospital, Providence

Sponsors

Collaborators (1)

Brown University

All Listed Sponsors

collaborator

Brown University

OTHER

lead

Rhode Island Hospital

OTHER

NCT04204434 - Biomarkers For Immune Checkpoint Inhibitors | Biotech Hunter | Biotech Hunter